SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The GUMMMy Bear Squad touting Gum Tech (NASDAQ: GUMM)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Hank who wrote (135)2/6/2000 3:26:00 AM
From: Carl R.   of 207
 
I agree that if people have a bad experience with the product on their first try they will abandon it. On the other hand, if it works the first time, but not the second then what? Will they use more of it? Will they keep using it until they finally get well and credit it to the Zicam? Or will they abandon it? Or will they reach the correct conclusion that the product works on some colds, but not on others? This will be interesting as it develops.

Even though you are short the stock, you apparently bought a sample of the product, which I also would have done if I had been in your shoes. If you haven't discarded it, you might continue to experiment on yourself if you start coming down with another cold. So far on me the score is 3 successes, 1 failure. For me that's good enough odds that I will keep some around. I certainly prefer the Zicam to the colds, and if I can get over even a few colds in just a day, that's great! I have 2 young boys (3-5) who go out into the world every day to collect viruses, so I expect to have plenty more opportunities to test the product before summer. <G>

Carl
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext